NEW YORK, March 16, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including HealthSouth (NYSE: HLS), Capital Senior Living (NYSE: CSU), Davita (NYSE: DVA), Envision (NYSE: EVHC), and Five Star Quality Care (NYSE: FVE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
HLS Research Report: ( http://get.analystsreview.com/pdf/?c=HealthSouth&d=16-Mar-2015&s=HLS ),
CSU Research Report: ( http://get.analystsreview.com/pdf/?c=Capital%20Senior%20Living&d=16-Mar-2015&s=CSU ),
DVA Research Report: ( http://get.analystsreview.com/pdf/?c=Davita&d=16-Mar-2015&s=DVA ),
EVHC Research Report: ( http://get.analystsreview.com/pdf/?c=Envision&d=16-Mar-2015&s=EVHC ),
FVE Research Report: ( http://get.analystsreview.com/pdf/?c=Five%20Star%20Quality%20Care&d=16-Mar-2015&s=FVE ).
============
--
Analyst Update: Quarterly Results and Disease Awareness Initiatives
U.S. stocks ended lower on Friday as mixed economic data during the week, renewed dollar strength and sharply lower oil prices made traders cautious ahead of the upcoming meeting of the Federal Open Market Committee. The consumer sentiment data showed a preliminary read of 91.2 in March versus 95.4 in February. The Dow Jones Industrial Average lost 145.91 points, or 0.82%, to close at 17,749.31. The S&P 500 fell 12.55 points, or 0.61%, to end at 2,053.40. The Nasdaq Composite was down 21.53 points, or 0.44%, to 4,871.76. European equities closed slightly higher Friday as the oil and gas sector took another hit from tumbling prices. The German DAX gained 0.87%, the French CAC gained 0.46% while the FTSE ended the day 0.30% down. In Asia, Chinese shares advanced, led by financials after People's Bank of China Governor said the bank will maintain its prudent monetary policy. Japan's Nikkei 225 hit a fresh 15-year high as robot maker Fanuc Corp jumped 13% on a report that it will consider raising its dividend and buying back stock.
HealthSouth Corporation (HealthSouth) recorded net income of $0.44 per diluted share in Q4 2014 versus net loss of $0.31 per diluted share in Q4 2013. Revenue for the quarter increased 7.2% YoY to $613.4 million, led by a 4.7% increase in patient discharges and a 3.2% increase in net patient revenue per discharge. The Company also gave its guidance for 2015.
Capital Senior Living Corporation (Capital Senior Living) has announced its Q4 and full-year 2014 financial results. Revenue for the quarter increased 12.6% YoY to $100.2 million, while adjusted EBITDAR was approximately $36.0 million, up 20.9% YoY. Net loss for the quarter stood at $3.9 million versus $2.4 million in Q4 2013.
DaVita healthCare Partners Inc.'s (Davita) division DaVita Kidney Care is encouraging people to learn about their risk for chronic kidney disease during March, National Kidney Month. In its initiative, the Company is conducting a 60-seconds quiz and is also providing resources for high risk populations - those with diabetes, high blood pressure and minority populations.
Envision Healthcare Holdings, Inc.'s (Envision) adjusted EPS for 2014 increased 76.5% YoY to $1.20. Adjusted EBITDA for the year was up 24.8% YoY to $556.2 million, while revenue grew 18.0% YoY to $4.4 million. The Company also reaffirmed its guidance for 2015.
Five Star Quality Care, Inc.'s (Five Star Quality Care) total revenues for the third quarter of 2014 increased 3.1% to $334.3 million. Net loss for the quarter was $3.0 million, or $0.06 per diluted share, compared to a net loss of $0.8 million, or $0.02 per diluted share, in Q3 2013.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
